Aktuellt
SENASTE
Redeye provides a research update on Lipum following the Q2 report published by the company earlier today. We make some adjustments to our estimates following a higher cash burn than expected and the outcome of the recent rights issue. Accordingly, we slightly lower our fair value range (SEK4 – SEK32) with a revised base case valuation of SEK20 (22) as we continue to see significant upside potential in the stock.
LÄS MER
